BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 20924726)

  • 1. Advances in the evaluation and management of minimal hepatic encephalopathy.
    Montgomery JY; Bajaj JS
    Curr Gastroenterol Rep; 2011 Feb; 13(1):26-33. PubMed ID: 20924726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimal hepatic encephalopathy.
    Sharma P
    J Assoc Physicians India; 2009 Nov; 57():760-3. PubMed ID: 20329443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolving concepts: the negative effect of minimal hepatic encephalopathy and role for prophylaxis in patients with cirrhosis.
    Prakash RK; Kanna S; Mullen KD
    Clin Ther; 2013 Sep; 35(9):1458-73. PubMed ID: 23972578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy.
    Jain L; Sharma BC; Srivastava S; Puri SK; Sharma P; Sarin S
    J Gastroenterol Hepatol; 2013 Jul; 28(7):1187-93. PubMed ID: 23425082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and treatment of minimal hepatic encephalopathy to prevent motor vehicle accidents: a cost-effectiveness analysis.
    Bajaj JS; Pinkerton SD; Sanyal AJ; Heuman DM
    Hepatology; 2012 Apr; 55(4):1164-71. PubMed ID: 22135042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal hepatic encephalopathy: A review.
    Nardone R; Taylor AC; Höller Y; Brigo F; Lochner P; Trinka E
    Neurosci Res; 2016 Oct; 111():1-12. PubMed ID: 27153746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life in patients with minimal hepatic encephalopathy.
    Ridola L; Nardelli S; Gioia S; Riggio O
    World J Gastroenterol; 2018 Dec; 24(48):5446-5453. PubMed ID: 30622374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.
    Sharma P; Sharma BC; Sarin SK
    Liver Int; 2009 Oct; 29(9):1365-71. PubMed ID: 19555401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal hepatic encephalopathy.
    Stinton LM; Jayakumar S
    Can J Gastroenterol; 2013 Oct; 27(10):572-4. PubMed ID: 24106728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectral electroencephalogram in liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
    Singh J; Sharma BC; Maharshi S; Puri V; Srivastava S
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1203-9. PubMed ID: 26716736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal hepatic encephalopathy matters in daily life.
    Bajaj JS
    World J Gastroenterol; 2008 Jun; 14(23):3609-15. PubMed ID: 18595126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal hepatic encephalopathy in children with chronic liver disease: Prevalence, pathogenesis and magnetic resonance-based diagnosis.
    Srivastava A; Chaturvedi S; Gupta RK; Malik R; Mathias A; Jagannathan NR; Jain S; Pandey CM; Yachha SK; Rathore RKS
    J Hepatol; 2017 Mar; 66(3):528-536. PubMed ID: 27815224
    [TBL] [Abstract][Full Text] [Related]  

  • 13.  Minimal hepatic encephalopathy in cirrhosis- how long to treat?
    Goyal O; Sidhu SS; Kishore H
    Ann Hepatol; 2017 Jan-Feb 2017; 16(1):115-122. PubMed ID: 28051800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy.
    Mittal VV; Sharma BC; Sharma P; Sarin SK
    Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):725-32. PubMed ID: 21646910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current approach to treatment of minimal hepatic encephalopathy in patients with liver cirrhosis.
    Moran S; López-Sánchez M; Milke-García MDP; Rodríguez-Leal G
    World J Gastroenterol; 2021 Jun; 27(22):3050-3063. PubMed ID: 34168407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can Lactobacillus acidophilus improve minimal hepatic encephalopathy? A neurometabolite study using magnetic resonance spectroscopy.
    Ziada DH; Soliman HH; El Yamany SA; Hamisa MF; Hasan AM
    Arab J Gastroenterol; 2013 Sep; 14(3):116-22. PubMed ID: 24206740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal hepatic encephalopathy.
    Dhiman RK; Chawla YK
    Indian J Gastroenterol; 2009; 28(1):5-16. PubMed ID: 19529896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sleep disturbances in patients of liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
    Singh J; Sharma BC; Puri V; Sachdeva S; Srivastava S
    Metab Brain Dis; 2017 Apr; 32(2):595-605. PubMed ID: 28070704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcopenia and cognitive impairment in liver cirrhosis: A viewpoint on the clinical impact of minimal hepatic encephalopathy.
    Nardelli S; Gioia S; Faccioli J; Riggio O; Ridola L
    World J Gastroenterol; 2019 Sep; 25(35):5257-5265. PubMed ID: 31558871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of cognitivity, proinflammatory cytokines, and brain magnetic resonance imaging in minimal hepatic encephalopathy induced by cirrhosis and extrahepatic portal vein obstruction.
    Yadav SK; Goel A; Saraswat VA; Thomas MA; Wang E; Marincola FM; Haris M; Gupta RK
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1986-1994. PubMed ID: 27119420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.